Susquehanna International Group
OCEA

Susquehanna International Group’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Susquehanna International Group’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-98,427
Closed -$5.32K – 14022
2025
Q1 		$5.32K Buy
+98,427
New +$23.5K ﹤0.01% 12258

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Susquehanna International Group's OCEA Position: Q2 2025 in Review

Susquehanna International Group sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 98,427 shares — an estimated $5.32K sold.

Susquehanna International Group first reported a position in OCEA in Q1 2025 and held it in 1 quarter. The position peaked at $5.32K in Q1 2025. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Susquehanna International Group reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 98,427 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $5.32K.
  • Susquehanna International Group first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
  • Susquehanna International Group's Ocean Biomedical, Inc. Common Stock position peaked at $5.32K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.